Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Cardiovascular disorder? 146 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Cardiovascular disorder have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.

146
Reports of Cardiovascular disorder with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
32
Deaths
70
Hospitalizations

How Dangerous Is Cardiovascular disorder From LENALIDOMIDE?

Of the 146 reports, 32 (21.9%) resulted in death, 70 (47.9%) required hospitalization, and 3 (2.1%) were considered life-threatening.

Is Cardiovascular disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 146 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Cardiovascular disorder?

ADALIMUMAB (482) ACETAMINOPHEN\PROPOXYPHENE (453) TESTOSTERONE (434) PROPOXYPHENE (399) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (354) CRESTOR (319) TESTOSTERONE CYPIONATE (221) LEVOFLOXACIN (213) METHOTREXATE (206) RITUXIMAB (193)

Which LENALIDOMIDE Alternatives Have Lower Cardiovascular disorder Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Cardiovascular disorder Reports All Drugs Causing Cardiovascular disorder LENALIDOMIDE Demographics